×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Contact Us
About Us
Subscribe
My Portfolio
My Account
Contact Us
About Us
Subscribe
My Account
My Portfolio

Insider Transactions by Shendelman Shoshana

Symbol CompanyOwnerRelationshipDateTransactionCost# SharesValue ($)Total SharesFiling
APLTApplied Therapeutics, Inc.Shendelman ShoshanaPresident and CEOAug 13, 2024Sale$6.18357,4232,208,8744,810,430Aug 14, 2024, 07:01 PM
APLTApplied Therapeutics, Inc.Shendelman ShoshanaPresident and CEOAug 14, 2024Sale$5.93119,591709,1754,690,839Aug 14, 2024, 07:01 PM
APLTApplied Therapeutics, Inc.Shendelman ShoshanaPresident and CEOAug 12, 2024Sale$5.98300,0001,794,0005,167,853Aug 14, 2024, 07:01 PM
APLTApplied Therapeutics, Inc.Shendelman ShoshanaPresident and CEOJun 06, 2024Sale$4.3261,795266,9543,756,019Jun 10, 2024, 04:29 PM
APLTApplied Therapeutics, Inc.Shendelman ShoshanaPresident and CEOMar 14, 2024Sale$5.39318,5731,717,1083,817,814Mar 18, 2024, 06:12 PM
APLTApplied Therapeutics Inc.Shendelman ShoshanaPresident and CEONov 30, 2023Sale$1.973,9687,8172,596,387Dec 01, 2023, 07:42 PM
APLTApplied Therapeutics Inc.Shendelman ShoshanaPresident and CEOSep 27, 2023Sale$2.70115,632312,2062,600,355Sep 29, 2023, 08:03 PM
APLTApplied Therapeutics Inc.Shendelman ShoshanaPresident and CEOJan 11, 2023Sale$0.9115,87014,442751,625Jan 13, 2023, 04:34 PM
APLTApplied Therapeutics Inc.Shendelman ShoshanaPresident and CEOOct 14, 2022Buy$0.6450,00032,250767,495Oct 14, 2022, 05:41 PM
APLTApplied Therapeutics Inc.Shendelman ShoshanaPresident and CEOOct 13, 2022Buy$0.5673,25640,891717,495Oct 13, 2022, 06:17 PM
APLTApplied Therapeutics Inc.Shendelman ShoshanaPresident and CEOOct 12, 2022Buy$0.5238,15319,943644,239Oct 12, 2022, 08:51 PM
APLTApplied Therapeutics Inc.Shendelman ShoshanaPresident and CEOSep 13, 2021Buy$14.6970110,298354,986Sep 14, 2021, 04:44 PM
APLTApplied Therapeutics Inc.Shendelman ShoshanaPresident and CEOSep 14, 2021Buy$14.499,300134,740364,286Sep 14, 2021, 04:44 PM
APLTApplied Therapeutics Inc.Shendelman ShoshanaPresident and CEOJul 20, 2020Sale$27.3415,000410,079557,185Jul 22, 2020, 09:55 PM
APLTApplied Therapeutics Inc.Shendelman ShoshanaPresident and CEOJul 21, 2020Option Exercise$1.4415,00021,600569,285Jul 22, 2020, 09:55 PM
APLTApplied Therapeutics Inc.Shendelman ShoshanaPresident and CEOJul 21, 2020Sale$27.0615,000405,834561,685Jul 22, 2020, 09:55 PM
APLTApplied Therapeutics Inc.Shendelman ShoshanaPresident and CEOJul 22, 2020Option Exercise$1.4415,00021,600569,285Jul 22, 2020, 09:55 PM
APLTApplied Therapeutics Inc.Shendelman ShoshanaPresident and CEOJul 22, 2020Sale$25.6615,000384,876557,235Jul 22, 2020, 09:55 PM
APLTApplied Therapeutics Inc.Shendelman ShoshanaPresident and CEOJul 20, 2020Option Exercise$1.4415,00021,600569,285Jul 22, 2020, 09:55 PM
APLTApplied Therapeutics Inc.Shendelman ShoshanaPresident and CEOJul 07, 2020Sale$32.1715,000482,513567,290Jul 09, 2020, 09:55 PM
APLTApplied Therapeutics Inc.Shendelman ShoshanaPresident and CEOJul 08, 2020Option Exercise$1.4415,00021,600569,285Jul 09, 2020, 09:55 PM
APLTApplied Therapeutics Inc.Shendelman ShoshanaPresident and CEOJul 08, 2020Sale$32.3215,000484,775556,396Jul 09, 2020, 09:55 PM
APLTApplied Therapeutics Inc.Shendelman ShoshanaPresident and CEOJul 09, 2020Option Exercise$1.4415,00021,600569,285Jul 09, 2020, 09:55 PM
APLTApplied Therapeutics Inc.Shendelman ShoshanaPresident and CEOJul 09, 2020Sale$31.1015,000466,507558,349Jul 09, 2020, 09:55 PM
APLTApplied Therapeutics Inc.Shendelman ShoshanaPresident and CEOJul 07, 2020Option Exercise$1.4415,00021,600569,285Jul 09, 2020, 09:55 PM
APLTApplied Therapeutics Inc.Shendelman ShoshanaPresident and CEOMay 28, 2020Option Exercise$1.34125,000167,845679,285Jun 01, 2020, 07:52 PM
APLTApplied Therapeutics Inc.Shendelman ShoshanaPresident and CEOMay 28, 2020Sale$42.70125,0005,337,500554,285Jun 01, 2020, 07:52 PM
APLTApplied Therapeutics Inc.Shendelman ShoshanaPresident and CEOMay 16, 2019Buy$10.00125,0001,250,0003,605,662May 20, 2019, 05:09 PM

Looking for more premium content?

We have created a comprehensive group of tools that allows you to estimate the intrinsic value of investments.

Subscribe